Publication | Open Access

Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaSingle-centre Phase 2HematologyPharmacologyPharmacotherapyAdult T-cell Leukemia-lymphomaMedicineMyeloid Neoplasia